30th Sep 2019 1:49 pm |
RNS |
Holding(s) in Company |
30th Sep 2019 12:11 pm |
RNS |
Holding(s) in Company |
30th Sep 2019 7:00 am |
RNS |
Chi-Med Surufatinib Phase III data at ESMO |
30th Sep 2019 7:00 am |
RNS |
Total Voting Rights |
25th Sep 2019 7:00 am |
RNS |
Chi-Med Presents SANET-ep Phase III data at ESMO |
18th Sep 2019 7:00 am |
RNS |
Chi-Med Highlights Presentations at 2019 CSCO |
3rd Sep 2019 7:19 am |
RNS |
Chi-Med to present at MS conference |
3rd Sep 2019 7:00 am |
RNS |
Chi-Med initiates Phase I trial |
30th Aug 2019 7:00 am |
RNS |
Total Voting Rights |
23rd Aug 2019 7:00 am |
RNS |
Start of Clinical Trial in China |
20th Aug 2019 7:48 am |
RNS |
Holding(s) in Company |
30th Jul 2019 10:48 am |
RNS |
TR-1: Form for notification of major holdings |
30th Jul 2019 7:00 am |
RNS |
2019 Interim Results and Clinical Programs Update |
10th Jul 2019 4:35 pm |
RNS |
Price Monitoring Extension |
3rd Jul 2019 7:00 am |
RNS |
Chi-Med to Announce 2019 Half-Year Results |
3rd Jul 2019 7:00 am |
RNS |
TR-1: Form for notification of major holdings |
28th Jun 2019 11:10 am |
RNS |
Blocklisting Six Monthly Return |
28th Jun 2019 10:07 am |
RNS |
Pricing of U.S. Public Secondary Offering of ADSs |
28th Jun 2019 7:00 am |
RNS |
Secondary Offering of American Depositary Shares |
21st Jun 2019 4:40 pm |
RNS |
Second Price Monitoring Extn |
21st Jun 2019 4:35 pm |
RNS |
Price Monitoring Extension |
19th Jun 2019 4:35 pm |
RNS |
Price Monitoring Extension |
14th Jun 2019 9:00 am |
RNS |
Surufatinib Phase III Study Meets Primary Endpoint |
12th Jun 2019 9:18 am |
RNS |
Block Admission Applications & Total Voting Rights |
10th Jun 2019 12:07 pm |
RNS |
Second Price Monitoring Extn |
10th Jun 2019 12:02 pm |
RNS |
Price Monitoring Extension |
6th Jun 2019 7:00 am |
RNS |
Disclosure Update |
31st May 2019 4:40 pm |
RNS |
Second Price Monitoring Extn |
31st May 2019 4:35 pm |
RNS |
Price Monitoring Extension |
29th May 2019 12:06 pm |
RNS |
Results of Extraordinary General Meeting |
22nd May 2019 11:03 am |
RNS |
Grant of Share Options under Share Option Scheme |
3rd May 2019 7:00 am |
RNS |
Notice of EGM & Shareholder Circular |
24th Apr 2019 1:54 pm |
RNS |
Results of AGM |
15th Apr 2019 7:30 am |
RNS |
Disclosure Update |
15th Apr 2019 7:00 am |
RNS |
HK Listing Application - Proposed Global Offering |
29th Mar 2019 7:00 am |
RNS |
Start of Phase IIb/III Surufatinib Trial in China |
28th Mar 2019 7:30 am |
RNS |
Savolitinib Lung Cancer Presentations at AACR |
25th Mar 2019 7:00 am |
RNS |
Vesting of awards under Long Term Incentive Plan |
21st Mar 2019 7:00 am |
RNS |
Chi-Med 2018 Annual Report and Notice of AGM |
11th Mar 2019 12:54 pm |
RNS |
Publication of Form 20-F |